The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) and Child–Pugh (CP)-B liver function treated with regorafenib in routine clinical practice in the observational REFINE study.
 
Yoon Jun Kim
Research Funding - AstraZeneca (Inst); Bayer (Inst); BTG (Inst); Daewoong Pharmaceutical (Inst); Gilead Sciences (Inst); Samjin (Inst); Yuhan (Inst)
 
Philippe Merle
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; EISAI; Ipsen; Lilly; Merck; Roche
Consulting or Advisory Role - Bayer Schering Pharma
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Hengrui Therapeutics; Lilly; Merck; Pfizer
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Masatoshi Kudo
Speakers' Bureau - Bayer; Chugai Pharma; Eisai; Lilly; MSD; Takeda
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); EA Pharma (Inst); Eisai (Inst); GE HealthCare (Inst); Gilead Sciences (Inst); Otsuka (Inst); Sumitomo Dainippon Pharma (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Heinz-Josef Klümpen
No Relationships to Disclose
 
Ho Yeong Lim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bayer
 
Matthias Pinter
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD; Roche
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Svetlana Babajanyan
Employment - Bayer
 
Javeed Khan
Employment - Bayer
 
Maria Awan
Employment - Bayer
 
Kirhan Özgürdal
Employment - Bayer
 
Shukui Qin
No Relationships to Disclose